483
Eosera, Inc.Eosera, Inc. – FDA 483, Apr 28, 2025
Record Details
An FDA inspection of Eosera, Inc. in Fort Worth, TX, identified two significant issues related to quality control and equipment maintenance for their OTC drug manufacturing operations. The firm failed to adequately follow written procedures for change management, specifically regarding a facility move, and lacked established cleaning validation procedures for equipment used in compounding OTC ear care products.
View Company Profile
ID · a5bd0ed3-25e7-4571-82cd-abe754c3ecdf
Other documents for Eosera, Inc.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.